Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02856516 · ClinicalTrials.gov registry record · NA
Glycemic Response to Three Oral Nutrition Supplements in Persons With Type 2 Diabetes Mellitus
A NA study, sponsored by Société des Produits Nestlé (SPN).
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT02856516 is a NA study that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 12 participants.
The verdict
NCT02856516, a NA study, has completed, sponsored by Société des Produits Nestlé (SPN).
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
This will be a randomized, cross-over design. Subjects will be randomized to one of three interventions on three separate study days, 1 week apart.
Interventions
- OTHER Boost Glucose Control (A)
- OTHER Boost Glucose Control (B)
- OTHER Boost Original
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2016-07 |
| Est. Completion | 2016-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02856516
The ClinicalTrials.gov registry entry for NCT02856516 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Société des Produits Nestlé (SPN), which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Boost Glucose Control (A) is the first listed.
NCT02856516 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02856516 about?
NCT02856516 is a clinical study titled "Glycemic Response to Three Oral Nutrition Supplements in Persons With Type 2 Diabetes Mellitus". This will be a randomized, cross-over design. Subjects will be randomized to one of three interventions on three separate study days, 1 week apart.
What is the current status of trial NCT02856516?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2016-07. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02856516?
The interventions under investigation include: Boost Glucose Control (A) (OTHER), Boost Glucose Control (B) (OTHER), Boost Original (OTHER).
Who is sponsoring clinical trial NCT02856516?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.